Respiratory tract control device and system in anesthesia process, computing equipment and medium

By obtaining and analyzing the respiratory parameters of anesthetized patients, calculating the comprehensive evaluation value of the respiratory tract, and adjusting the intensity of electrical stimulation based on this value, the problem of difficult to control the degree of respiratory patency in non-intubation general anesthesia is solved, and the level of respiratory management during anesthesia is improved , ensuring the safety and comfort of patients.

CN119405987APending Publication Date: 2025-02-11SHANGHAI FOURTH PEOPLES HOSPITAL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411399408.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-09
Publication Date
2025-02-11

AI Technical Summary

Technical Problem

During the anesthesia process, the degree of respiratory patency caused by non-intubation general anesthesia is difficult to effectively control, and risks such as respiratory depression and respiratory obstruction are prone to occur.

Method used

By obtaining the diaphragmatic myotomy parameters and respiratory flow parameters of the target organism, the comprehensive evaluation value of the respiratory tract is calculated, and the electrical stimulation intensity of the biological tissue associated with the respiratory tract is adjusted according to this value to improve the degree of airway patency.

Benefits of technology

It improves the level of airway control during anesthesia, reduces the risks of respiratory depression and respiratory obstruction, and ensures the safety and comfort of the patient.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119405987A_ABST
    Figure CN119405987A_ABST
Patent Text Reader

Abstract

The invention relates to a respiratory tract control device and system in an anesthesia process, computing equipment and a storage medium. The respiratory tract control device in the anesthesia process comprises a first acquisition module, a second acquisition module and a control module, wherein the first acquisition module is used for acquiring at least two respiratory parameters representing the smoothness degree of the respiratory tract of a target organism; the determination module is used for determining a comprehensive evaluation value of the respiratory tract of the target organism according to the at least two respiratory parameters; and the control module is used for increasing or decreasing the intensity of the electrical stimulation on the organism tissues associated with the respiratory tract according to the numerical value of the comprehensive evaluation value of the respiratory tract so as to improve the smoothness of the respiratory tract. According to the technical scheme, the control level on the respiratory tract in the anesthesia process is improved, and safety and comfort of the target organism can be well guaranteed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of medical devices, and in particular to a respiratory control device, system, computing equipment and storage medium during anesthesia. Background Art

[0002] With the advent of comfortable medical care, not only are more and more invasive operations requiring the participation of anesthesiologists, but more and more non-invasive examinations are also inseparable from anesthesiologists, such as gastroscopy, colonoscopy or painless abortion. In recent years, the demand for anesthesia outside these operating rooms has exploded. Due to the short operation or surgery time, more anesthesiologists have chosen non-intubation general anesthesia.

[0003] Non-intubation general anesthesia refers to general anesthesia without endotracheal intubation or laryngeal mask to manage the patient's airway. This method maintains airway patency and spontaneous breathing by regulating the depth of anesthesia, prohibits the use of muscle relaxants, and accounts for the vast majority of daytime anesthesia. For example, the main method of gastroscopy anesthesia is non-intubation general anesthesia, which can reduce the adverse reactions caused by operations such as endotracheal intubation and mechanical ventilation, and is beneficial to the patient's prognosis.

[0004] In the continuity assessment of sedation depth by the American Society of Anesthesiologists, deep sedation and general anesthesia can easily lead to insufficient spontaneous breathing and interfere with airway patency. Non-intubation general anesthesia has the characteristics of retaining spontaneous breathing, and patients are prone to risks such as respiratory depression and airway obstruction. This places higher demands on airway control during anesthesia. Summary of the invention

[0005] In view of this, the embodiments of the present application provide a respiratory control device, system, computing device and storage medium during anesthesia to solve at least one problem existing in the background technology.

[0006] To achieve the above purpose, the technical solution of this application is implemented as follows:

[0007] In a first aspect, an embodiment of the present application provides a respiratory tract control device during anesthesia, comprising:

[0008] A first acquisition module is used to acquire at least two respiratory parameters representing the patency of the respiratory tract of the target organism;

[0009] a determination module, configured to determine a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters;

[0010] The control module is used to increase or decrease the intensity of electrical stimulation to the biological tissue associated with the respiratory tract according to the numerical value of the comprehensive respiratory tract evaluation value, so as to improve the patency of the respiratory tract.

[0011] Optionally, the first acquisition module is specifically used to:

[0012] The values ​​of the at least two respiratory parameters of the target organism before and after anesthesia are obtained.

[0013] Optionally, the at least two respiratory parameters include: diaphragm electromyographic parameters and respiratory flow parameters;

[0014] The first acquisition module is also used for:

[0015] obtaining a first diaphragm electromyographic value and a first respiratory flow rate of the target organism before anesthesia;

[0016] obtaining a second diaphragm myoelectric value and a second respiratory flow rate of the target organism after anesthesia;

[0017] The first diaphragm EMG value and the second diaphragm EMG value are respectively measured values ​​of the diaphragm EMG parameter, and the first respiratory flow and the second respiratory flow are respectively measured values ​​of the respiratory flow parameter.

[0018] Optionally, the first acquisition module is further used for:

[0019] Acquire a first respiratory resistance value and a second respiratory resistance value;

[0020] The first respiratory resistance value is a ratio of the first respiratory flow rate to the first diaphragm myoelectric value; the second respiratory resistance value is a ratio of the second respiratory flow rate to the second diaphragm myoelectric value.

[0021] Optionally, the determining module is specifically used to:

[0022] normalizing the second respiratory flow to obtain a first intermediate parameter;

[0023] Normalizing the second respiratory resistance value to obtain a second intermediate parameter;

[0024] The first intermediate parameter and the second intermediate parameter are assigned different weights and then added to determine the comprehensive respiratory tract assessment value.

[0025] Optionally, the determining module is further used for:

[0026] Determine a minimum respiratory flow rate and a maximum respiratory flow rate according to the first respiratory flow rate;

[0027] determining a first difference between the second respiratory flow and the minimum respiratory flow;

[0028] determining a second difference between the maximum respiratory flow and the minimum respiratory flow;

[0029] The first difference is divided by the second difference to perform normalization processing to obtain the first intermediate parameter.

[0030] Optionally, the determining module is further used for:

[0031] The first respiratory flow is multiplied by a first coefficient to obtain the maximum respiratory flow, and the first respiratory flow is multiplied by a second coefficient to obtain the minimum respiratory flow; the first coefficient is 0.5-1.2, and the second coefficient is 0.3-0.8; the maximum respiratory flow is greater than the minimum respiratory flow.

[0032] Optionally, the determining module is further used for:

[0033] Determine a minimum respiratory resistance value and a maximum respiratory resistance value according to the first respiratory resistance value;

[0034] determining a third difference between the second breathing resistance value and the minimum breathing resistance value;

[0035] determining a fourth difference between the maximum breathing resistance value and the minimum breathing resistance value;

[0036] The third difference is divided by the fourth difference to perform normalization processing to obtain the second intermediate parameter.

[0037] Optionally, the determining module is further used for:

[0038] The first respiratory resistance value is multiplied by a third coefficient to obtain the maximum respiratory resistance value, and the first respiratory resistance value is multiplied by a fourth coefficient to obtain the minimum respiratory resistance value; the third coefficient is 0.5-1.2, and the fourth coefficient is 0.3-0.8; the maximum respiratory resistance value is greater than the minimum respiratory resistance value.

[0039] Optionally, the control module is specifically used for:

[0040] When the comprehensive respiratory tract assessment value is less than or equal to a first preset value, the intensity of the electrical stimulation is controlled to increase; when the comprehensive respiratory tract assessment value is greater than or equal to a second preset value, the intensity of the electrical stimulation is controlled to decrease; otherwise, the intensity of the electrical stimulation is kept unchanged.

[0041] Optionally, the device further comprises:

[0042] The second acquisition module is used to acquire at least one monitoring parameter of the target organism; the at least one monitoring parameter includes end-tidal carbon dioxide and / or blood oxygen saturation.

[0043] Optionally, the device further comprises:

[0044] The monitoring module is used to issue an alarm message when it is detected that at least one monitoring parameter exceeds a preset range.

[0045] In a second aspect, an embodiment of the present application provides a respiratory control system during anesthesia, comprising:

[0046] Electrode equipment;

[0047] The airway control device during anesthesia as described in the first aspect; the airway control device during anesthesia is communicatively connected to the electrode device, and the electrode device is used to increase or decrease the intensity of electrical stimulation to biological tissue associated with the airway.

[0048] In a third aspect, an embodiment of the present application provides a computing device, including a storage component, a communication bus, and a processing component, wherein:

[0049] The storage component is used to store the operating program of the airway control device during anesthesia;

[0050] The communication bus is used to realize the connection and communication between the storage component and the processing component;

[0051] The processing component is used to execute the operating program of the airway control device during anesthesia to achieve the following steps:

[0052] Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract;

[0053] determining a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters;

[0054] According to the numerical value of the comprehensive respiratory tract assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

[0055] In a fourth aspect, an embodiment of the present application provides a computer-readable storage medium, wherein an executable program is stored on the computer-readable storage medium.

[0056] When the executable program is executed by the processor, the following steps are implemented:

[0057] Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract;

[0058] determining a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters;

[0059] According to the numerical value of the comprehensive respiratory tract assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

[0060] The respiratory control device, system, computing device and storage medium provided in the anesthesia process by the embodiments of the present application include: a first acquisition module for acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract; a determination module for determining the comprehensive evaluation value of the respiratory tract of the target organism based on the at least two respiratory parameters; and a control module for increasing or decreasing the intensity of electrical stimulation to the biological tissue associated with the respiratory tract based on the value of the comprehensive evaluation value of the respiratory tract to improve the patency of the respiratory tract. In the embodiments of the present application, the comprehensive evaluation value of the respiratory tract of the target organism is determined by at least two respiratory parameters that characterize the patency of the respiratory tract, and the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased based on the value of the comprehensive evaluation value of the respiratory tract to improve the patency of the respiratory tract, thereby improving the level of control over the respiratory tract during anesthesia and better ensuring the safety and comfort of the target organism.

[0061] Additional aspects and advantages of the present application will be given in part in the description below, and in part will become apparent from the description below, or will be learned through the practice of the present application. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:

[0063] Figure 1 A schematic diagram of the structure of a respiratory control device during anesthesia provided by an embodiment of the present application;

[0064] Figure 2 A schematic diagram of an application scenario of a respiratory control device during anesthesia provided by an embodiment of the present application;

[0065] Figure 3 A schematic diagram of the structure of another respiratory control device during anesthesia provided by an embodiment of the present application;

[0066] Figure 4 A schematic diagram of the structure of another airway control device during anesthesia provided in an embodiment of the present application;

[0067] Figure 5 A schematic flow chart of the execution process of the airway control device during anesthesia provided by an embodiment of the present application;

[0068] Figure 6 A detailed flowchart of the execution process of the airway control device during anesthesia provided by an embodiment of the present application;

[0069] Figure 7A schematic diagram of a respiratory control system during anesthesia provided in an embodiment of the present application;

[0070] Figure 8 A schematic diagram of the structure of a computing device provided in an embodiment of the present application.

[0071] Description of reference numerals:

[0072] 100. Airway control device during anesthesia; 101. First acquisition module; 102. Determination module; 103. Control module; 104. Second acquisition module; 105. Monitoring module; 800. Computing device; 801. Storage component; 802. Communication bus; 803. Processing component; 804. Input device; 805. Output device; 806. External communication interface. DETAILED DESCRIPTION

[0073] The exemplary embodiments disclosed in the present application will be described in more detail below with reference to the accompanying drawings. Although the exemplary embodiments of the present application are shown in the accompanying drawings, it should be understood that the present application can be implemented in various forms and should not be limited by the specific embodiments described herein. On the contrary, these embodiments are provided to enable a more thorough understanding of the present application and to fully convey the scope disclosed in the present application to those skilled in the art.

[0074] In the following description, a large number of specific details are given in order to provide a more thorough understanding of the present application. However, it is obvious to those skilled in the art that the present application can be implemented without one or more of these details. In other examples, in order to avoid confusion with the present application, some technical features well known in the art are not described; that is, all features of the actual embodiments are not described here, and well-known functions and structures are not described in detail.

[0075] In order to thoroughly understand the present application, detailed steps and detailed structures will be presented in the following description to illustrate the technical solution of the present application. The preferred embodiments of the present application are described in detail below, but in addition to these detailed descriptions, the present application may also have other implementation methods.

[0076] Under anesthesia, patients are prone to "upper airway collapse". "Upper airway collapse" can be understood as "under anesthesia, the soft tissue around the patient's upper airway relaxes, and the relaxed soft tissue falls downward with gravity, causing the airway to narrow and block". When the respiratory airflow passes through the narrow part, the resistance increases, the amount of respiratory air that can pass through decreases, and the inhaled oxygen decreases accordingly. The resulting hypoxia is very dangerous. Studies have shown that the incidence of hypoxemia in grade I and II patients recognized by the American Society of Anesthesiologists (ASA) during endoscopic examinations is about 51%, and the incidence of apnea during procedural sedation and analgesia outside the operating room is about 54.2%, of which 37.8% of patients suffer from hypoxemia.

[0077] The key to airway management during non-intubation general anesthesia is to detect respiratory depression as early as possible and deal with airway obstruction in a timely manner. In the related art, by monitoring end-tidal carbon dioxide (ETCO2), observing the expansion and contraction of the air storage bag, observing the tidal changes of nasal mask exhalation, observing abdominal breathing movements (insensitive) or monitoring pulse oxygen saturation (delayed for several minutes), it is determined whether respiratory depression occurs. However, a single parameter or manual observation has the problem of inaccurate and untimely judgment, which affects the patient's personal safety. In addition, the methods of dealing with airway obstruction in the related art include jaw support, manual positive pressure ventilation, or the use of laryngeal mask and endotracheal intubation. These treatment methods, on the one hand, require more manual intervention, and on the other hand, the operation is complicated, and may hinder treatment operations such as gastroscopy. Therefore, the requirements for airway control devices during anesthesia are getting higher and higher, in order to improve the level of control of the airway during anesthesia, and thus ensure the safety and comfort of patients.

[0078] Based on this, the present application proposes the following technical solutions.

[0079] Embodiment 1

[0080] The present application embodiment provides a respiratory control device 100 during anesthesia, referring to Figure 1 , the airway control device 100 during anesthesia may include:

[0081] A first acquisition module 101 is used to acquire at least two respiratory parameters representing the patency of the respiratory tract of the target organism;

[0082] A determination module 102, for determining a comprehensive respiratory assessment value of a target organism based on at least two respiratory parameters;

[0083] The control module 103 is used to increase or decrease the intensity of electrical stimulation to the biological tissue associated with the respiratory tract according to the numerical value of the comprehensive evaluation value of the respiratory tract, so as to improve the patency of the respiratory tract.

[0084] In an embodiment of the present application, a comprehensive respiratory assessment value of the target organism is determined by at least two respiratory parameters that characterize the patency of the respiratory tract, and based on the numerical value of the comprehensive respiratory assessment value, the intensity of electrical stimulation of biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract. This improves the level of control over the respiratory tract during anesthesia and can better ensure the safety and comfort of the target organism.

[0085] It should be noted that in the embodiments of the present application, the intensity of the electrical stimulation can be characterized by the intensity of the current applied to the electrical stimulation. Specifically, for example, by increasing or decreasing the current value of the applied electrical stimulation, the intensity of the electrical stimulation on the biological tissue associated with the respiratory tract can be increased or decreased.

[0086] In practical applications, such as Figure 2 As shown, at least two respiratory parameters characterizing the patency of the respiratory tract can be obtained by at least two of the respiratory flow sensor, nasal oxygen tube, electromyographic electrode and blood oxygen saturation sensor arranged at the corresponding parts of the target organism. Electrical stimulation can be applied to the biological tissue associated with the respiratory tract by wearing the intermediate frequency electrode under the chin of the target organism to electrically stimulate the genioglossus muscle and the hypoglossal nerve branch, so as to promote the stress contraction of the genioglossus muscle, increase the contraction tension of the respiratory tract, and thus improve the patency of the respiratory tract. In this way, the intermediate frequency electrode is worn outside the body, which is a non-invasive operation, and the operation is simple, the comfort is good, and the applicability is wide. In some other embodiments of the present application, it is not excluded to apply electrical stimulation to the biological tissue associated with the respiratory tract in other ways, such as setting the electrode in the oral cavity of the target organism to apply electrical stimulation to the biological tissue associated with the respiratory tract. In addition, the acquired respiratory parameters (such as diaphragm electromyographic value, respiratory flow, end-tidal carbon dioxide, blood oxygen saturation, etc.) and the intensity of the electrical stimulation can be displayed on the display screen to facilitate medical staff to view and control.

[0087] In some embodiments, the first acquisition module 101 may be specifically used for:

[0088] The values ​​of at least two respiratory parameters of the target organism before and after anesthesia are obtained.

[0089] In the embodiment of the present application, by obtaining the values ​​of at least two respiratory parameters of the target organism before and after anesthesia, respectively, it is convenient to use the values ​​of the at least two respiratory parameters obtained before anesthesia as a reference, combined with the values ​​of the at least two respiratory parameters obtained after anesthesia, to provide a basis for the next step of accurately evaluating the patency of the airway of the target organism after anesthesia.

[0090] It should be noted that, before anesthesia in the embodiments of the present application refers to the period before the anesthetic operation is performed on the target organism, when the target organism is awake and in a stable physical state; and after anesthesia includes the period during which the anesthetic operation is performed on the target organism, the period during which the target organism is in an anesthetic state, and the period during which the target organism recovers from anesthesia.

[0091] In some embodiments, the at least two respiratory parameters may include: diaphragm electromyography parameters and respiratory flow parameters; the first acquisition module 101 is further used to:

[0092] obtaining a first diaphragm electromyographic value and a first respiratory flow rate of the target organism before anesthesia;

[0093] obtaining a second diaphragm myoelectric value and a second respiratory flow rate of the target organism after anesthesia;

[0094] The first diaphragm electromyographic value and the second diaphragm electromyographic value are respectively measured values ​​of diaphragm electromyographic parameters, and the first respiratory flow and the second respiratory flow are respectively measured values ​​of respiratory flow parameters.

[0095] The diaphragm is the most important respiratory muscle of the respiratory system. The inhalation and exhalation of gas rely on the work of the diaphragm to form positive and negative pressures in the alveoli, thereby forming breathing. Therefore, measuring the diaphragm electromyographic parameters can directly and accurately reflect the real respiratory drive and respiratory load of the target object. In this embodiment, by obtaining the diaphragm electromyographic parameters and the respiratory flow parameters, the degree of patency of the airway of the target organism can be reflected very timely and accurately, thereby providing a basis for obtaining a more accurate comprehensive evaluation value of the respiratory tract in the future. In addition, the respiratory resistance value can be further obtained according to the numerical values ​​of the diaphragm electromyographic parameters and the numerical values ​​of the respiratory flow parameters. For the specific method of obtaining the respiratory resistance value, please refer to the introduction below. In some other embodiments of the present application, it is not excluded that the respiratory parameters include other physiological parameters, such as blood oxygen saturation, respiratory rate or end-tidal carbon dioxide.

[0096] Exemplarily, surface electromyographic electrodes can be used to collect diaphragm electromyographic signals to obtain the values ​​of diaphragm electromyographic parameters. In practical applications, if diaphragm electromyographic detection is used, the respiratory rate can also be detected. The method of obtaining respiratory parameters may include, for example, at least one of impedance respiratory detection, temperature and / or humidity detection, airflow detection, etc. Among them, the operating forms of different respiratory detection methods may also be different. For example, for impedance respiratory detection, electrodes need to be attached; for temperature and / or humidity detection, it needs to be placed in the nostrils, and a temperature and humidity sensor or a temperature sensor or a humidity sensor can be used; for airflow detection, it also needs to be placed in the nostrils. Optionally, the respiratory signal can be obtained by temperature detection. Specifically, a fast-response thermistor is used as a temperature sensor and placed in the nose, which is easy to use and low in cost.

[0097] In the embodiment of the present application, the first diaphragm EMG value and the first respiratory flow before anesthesia can be recorded as EMG0 and F0, respectively, and the second diaphragm EMG value and the second respiratory flow after anesthesia can be recorded as EMGx and Fx, respectively.

[0098] In some embodiments, the first acquisition module 101 may also be used to:

[0099] Acquire a first respiratory resistance value and a second respiratory resistance value;

[0100] The first respiratory resistance value is the ratio of the first respiratory flow rate to the first diaphragm myoelectric value; the second respiratory resistance value is the ratio of the second respiratory flow rate to the second diaphragm myoelectric value.

[0101] In the embodiment of the present application, the respiratory resistance value is obtained by the ratio of the respiratory flow and the diaphragm electromyography value. For example, when the airway is not patency is poor, the respiratory flow will decrease, and the diaphragm will increase the respiratory driving force, causing the diaphragm electromyography value to increase. At this time, the respiratory resistance value is smaller. Therefore, the respiratory resistance value can more comprehensively reflect the patency of the target organism's respiratory tract, and then reflect whether the target organism's respiratory state is good.

[0102] In the embodiment of the present application, the first respiratory resistance value may be recorded as L0, where L0=F0 / EMG0, and the second respiratory resistance value may be recorded as Lx, where Lx=Fx / EMGx.

[0103] In some embodiments, the determination module 102 may be specifically configured to:

[0104] normalizing the second respiratory flow to obtain a first intermediate parameter;

[0105] Normalizing the second respiratory resistance value to obtain a second intermediate parameter;

[0106] The first intermediate parameter and the second intermediate parameter are assigned different weights and then added to determine a comprehensive respiratory tract assessment value.

[0107] In the embodiment of the present application, by normalizing the second respiratory flow Fx and the second respiratory resistance value Lx to obtain the first intermediate parameter and the second intermediate parameter, the difference in dimension and unit between the second respiratory flow Fx and the second respiratory resistance value Lx can be removed, so that different parameters have better comparability. Further, by assigning different weights to the first intermediate parameter and the second intermediate parameter and then accumulating them to obtain a comprehensive respiratory evaluation value, the comprehensive respiratory evaluation value obtained in this way can more comprehensively and accurately reflect the patency of the respiratory tract, thereby improving the management level and reliability of the device.

[0108] The following example uses the maximum-minimum normalization method to normalize the second respiratory flow Fx and the second respiratory resistance value Lx. It can be understood that in some other embodiments of the present application, other normalization methods, such as standard deviation normalization, are not excluded for normalizing the second respiratory flow and the second respiratory resistance value.

[0109] In some embodiments, the determination module 102 may also be used to:

[0110] Determine a minimum respiratory flow rate and a maximum respiratory flow rate according to the first respiratory flow rate;

[0111] determining a first difference between the second respiratory flow and the minimum respiratory flow;

[0112] determining a second difference between the maximum respiratory flow and the minimum respiratory flow;

[0113] The first difference is divided by the second difference to perform normalization processing to obtain a first intermediate parameter.

[0114] In some specific embodiments, the determination module 102 can also be used to multiply the first respiratory flow F0 by the first coefficient a1 to obtain the maximum respiratory flow Fmax, and multiply the first respiratory flow F0 by the second coefficient a2 to obtain the minimum respiratory flow Fmin; the first coefficient a1 is 0.5-1.2, and the second coefficient a2 is 0.3-0.8; the maximum respiratory flow Fmax is greater than the minimum respiratory flow Fmin.

[0115] In the embodiment of the present application, the first intermediate parameter can be recorded as Fn, where Fn=((Fx-Fmin) / (Fmax-Fmin))*100.

[0116] In some embodiments, the determination module 102 may also be used to:

[0117] Determine a minimum respiratory resistance value and a maximum respiratory resistance value according to the first respiratory resistance value;

[0118] determining a third difference between the second breathing resistance value and the minimum breathing resistance value;

[0119] determining a fourth difference between the maximum breathing resistance value and the minimum breathing resistance value;

[0120] The third difference value is divided by the fourth difference value to perform normalization processing to obtain a second intermediate parameter.

[0121] In some specific embodiments, the determination module 102 can also be used to multiply the first breathing resistance value L0 by the third coefficient b1 to obtain the maximum breathing resistance value Lmax, and multiply the first breathing resistance value L0 by the fourth coefficient b2 to obtain the minimum breathing resistance value Lmin; the third coefficient b1 is 0.5-1.2, and the fourth coefficient b2 is 0.3-0.8; the maximum breathing resistance value Lmax is greater than the minimum breathing resistance value Lmin.

[0122] In the embodiment of the present application, the second intermediate parameter can be recorded as Ln, where Ln=((Lx-Lmin) / (Lmax-Lmin))*100.

[0123] In the embodiments of the present application, the comprehensive respiratory evaluation value can be recorded as Q. In some specific embodiments, Q = k1*Fn+k2*Ln, where k1+k2 = 1. Optionally, k1 is 0.3-0.7, and k2 is 0.3-0.7, so that the obtained comprehensive respiratory evaluation value Q can better balance the weights of respiratory flow and respiratory resistance values ​​and reduce errors.

[0124] It should be noted that the comprehensive respiratory assessment value Q ranges from 0 to 100. When the calculated Q value is greater than 100, the Q value is 100.

[0125] In some embodiments, the control module 103 may be specifically used to:

[0126] When the comprehensive respiratory tract assessment value is less than or equal to the first preset value, the intensity of electrical stimulation is controlled to increase; when the comprehensive respiratory tract assessment value is greater than or equal to the second preset value, the intensity of electrical stimulation is controlled to decrease; otherwise, the intensity of electrical stimulation is kept unchanged.

[0127] In the embodiment of the present application, the intensity of the electrical stimulation can be adaptively adjusted by the comprehensive respiratory evaluation value Q to control the intensity of the electrical stimulation within an appropriate range. In this way, on the one hand, the respiratory tract of the target organism can be kept in a relatively good state of patency, and on the other hand, discomfort to the target organism caused by a large degree of opening of the respiratory tract can be avoided, that is, comfort can be guaranteed while ensuring safety.

[0128] Specifically, the first preset value and the second preset value can be set in combination with clinical data and physical parameters of the target organism, etc. In some specific embodiments, the first preset value is greater than or equal to 60, and the second preset value is greater than or equal to 80 and less than or equal to 90.

[0129] Optionally, the first preset value is 60 and the second preset value is 80. In this case, when the comprehensive respiratory tract evaluation value Q is less than or equal to 60, indicating that the target organism's respiratory tract is less open, the intensity of the electrical stimulation is controlled to increase the degree of opening of the respiratory tract and ensure better patency of the respiratory tract; when the comprehensive respiratory tract evaluation value Q is greater than or equal to 80, indicating that the target organism's respiratory tract is more open, the intensity of the electrical stimulation is controlled to be reduced to avoid discomfort to the target organism due to excessive opening of the respiratory tract; when the comprehensive respiratory tract evaluation value Q is between 60-80 (excluding the endpoint value), it indicates that the target organism's respiratory tract is within an appropriate range and the intensity of the electrical stimulation can be kept unchanged.

[0130] In some other embodiments of the present application, it is not excluded that the intensity of electrical stimulation can be manually adjusted according to the comprehensive respiratory tract assessment value.

[0131] In some embodiments, please refer to Figure 3 The airway control device 100 during anesthesia may also include:

[0132] The second acquisition module 104 is used to acquire at least one monitoring parameter of the target biological body; the at least one monitoring parameter includes end-tidal carbon dioxide (ETCO2) and / or blood oxygen saturation (SpO2).

[0133] Both end-tidal carbon dioxide and blood oxygen saturation can characterize the vital signs of the target organism. In the embodiment of the present application, the safety of the target organism can be monitored by monitoring the values ​​of end-tidal carbon dioxide and / or blood oxygen saturation. In particular, after the intensity of the applied electrical stimulation is adjusted, the synchronous monitoring of the values ​​of ETCO2 and / or SpO2 can provide comprehensive feedback on the state of the target organism, thereby better ensuring the safety of the target organism.

[0134] In some embodiments, please refer to Figure 4 The airway control device 100 during anesthesia may also include:

[0135] The monitoring module 105 is used to issue an alarm message when it is detected that at least one monitoring parameter exceeds a preset range.

[0136] In an embodiment of the present application, when at least one monitoring parameter (such as ETCO2 and / or SpO2) is monitored to be outside a preset range, it indicates that the target organism may be in a dangerous state such as hypoxia. In particular, after adjusting the intensity of the electrical stimulation, if the patency of the respiratory tract still cannot be improved, causing the values ​​of ETCO2 and / or SpO2 to exceed the preset range, an alarm message can be issued to facilitate medical staff to know at the first time that the target organism is in danger, so as to intervene in time to ensure the safety of the target organism.

[0137] In some embodiments, the monitoring module 105 may also be configured to, in the step of controlling the increase in the intensity of electrical stimulation, issue an alarm message if it is monitored that the intensity of electrical stimulation has increased to a maximum value.

[0138] In an embodiment of the present application, if the comprehensive respiratory assessment value is less than or equal to the first preset value and the electrical stimulation intensity needs to be increased, if it is monitored that the electrical stimulation intensity has increased to the maximum value of the relevant equipment, an alarm message can be issued to facilitate medical staff to discover and deal with it in time, thereby better ensuring the reliability of the device and the safety of the target organism.

[0139] In order to more clearly understand the airway control device 100 during anesthesia provided by the embodiment of the present application, the execution process of the airway control device 100 during anesthesia provided by the embodiment of the present application will be introduced below. Figure 5 This is a flow chart of the execution process of the airway control device 100 during anesthesia provided in an embodiment of the present application, refer to Figure 5 , the execution process may include:

[0140] Step S101: acquiring at least two respiratory parameters representing the patency of the respiratory tract of a target organism;

[0141] Step S102: determining a comprehensive respiratory assessment value of the target organism based on at least two respiratory parameters;

[0142] Step S103: According to the numerical value of the comprehensive evaluation value of the respiratory tract, the intensity of the electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

[0143] Figure 6 A detailed flowchart of the execution process of the airway control device 100 during anesthesia provided in the embodiment of the present application is provided. Figure 6 As shown, the execution process may include:

[0144] Step 201: Start, program initialization.

[0145] Step 202: diaphragm electromyography detection to obtain a diaphragm electromyography value (EMG); that is, obtain a first diaphragm electromyography value (EMG0).

[0146] Step 203: Detect respiratory flow and obtain respiratory flow (F); that is, obtain the first respiratory flow (F0).

[0147] Step 204: Obtain the respiratory resistance value (L) according to the ratio of F to EMG; that is, obtain L0 according to F0 / EMG0.

[0148] Step 205: monitor end-tidal carbon dioxide (ETCO2) and blood oxygen saturation (SpO2); that is, continuously monitor ETCO2 and SpO2 before and after anesthesia.

[0149] Step 206: Start anesthesia. If yes, proceed to step 207. If no, proceed to step 202.

[0150] Step 207: The initial value has been recorded. If yes, proceed to step 209; if no, proceed to step 208.

[0151] Step 208: Record the initial values ​​EMG0, F0 and L0.

[0152] Step 209: Obtain a comprehensive respiratory assessment value (Q); that is, obtain a second respiratory resistance value (Lx) by acquiring a second respiratory flow (Fx) and a second diaphragm electromyography value (EMGx), and obtain Q based on F0, L0, Fx, and Lx.

[0153] Step 210: Q≤m; that is, whether the comprehensive respiratory assessment value Q is less than or equal to the first preset value m, if yes, proceed to step 211, if not, proceed to step 213.

[0154] Step 211: Control and enhance the intensity of electrical stimulation.

[0155] Step 212: The electrical stimulation intensity has reached the maximum value; if yes, proceed to step 216; if no, proceed to step 215.

[0156] Step 213: Q≥n; that is, whether the comprehensive respiratory tract assessment value Q is greater than or equal to the second preset value n, if yes, proceed to step 214, if not, proceed to step 215.

[0157] Step 214: Control to reduce the intensity of electrical stimulation.

[0158] Step 215: ETCO2 and / or SpO2 exceed the preset range; if yes, proceed to step 216; if no, proceed to step 202.

[0159] Step 216: Alarm. That is, when ETCO2 and / or SpO2 exceed the preset range or the electrical stimulation intensity has reached the maximum value, an alarm message is issued, and then the process continues to step 202.

[0160] It should be understood that although Figure 6 The steps in the flowchart are shown in sequence as indicated by the arrows, but these steps are not necessarily executed in the order indicated by the arrows. Unless otherwise specified in this document, there is no strict order restriction for the execution of these steps, and these steps can be executed in other orders. Moreover, Figure 6At least part of the steps may include multiple steps or multiple stages. These steps or stages are not necessarily performed at the same time, but can be performed at different times. The execution order of these steps or stages is not necessarily sequential, but can be performed in turn or alternately with other steps or at least part of the steps or stages in other steps.

[0161] In the embodiment of the present application, the respiratory resistance value is determined by combining the diaphragm electromyography value with the respiratory flow rate, and the comprehensive evaluation value of the respiratory tract is obtained according to the respiratory resistance value and the respiratory flow rate. According to the numerical value of the comprehensive evaluation value of the respiratory tract, medium and low frequency electrical stimulation can be applied to the biological tissue associated with the respiratory tract to assist in opening the collapsed respiratory tract during anesthesia, and the intensity of the stimulation can be adaptively adjusted. In addition, one or more parameters such as end-tidal carbon dioxide and blood oxygen saturation can be monitored as feedback. After assisting in opening the respiratory tract, when the physiological parameters are still outside the normal range, the device can alarm and remind medical staff. The embodiment of the present application adopts a comprehensive treatment and monitoring method, which can greatly reduce the medical risks caused by respiratory collapse during surgical anesthesia, improve the level of control over the respiratory tract during anesthesia, and better ensure the safety and comfort of the target organism.

[0162] Each module included in this embodiment can be implemented by a processor in a computer; of course, it can also be implemented by a logic circuit in a computer. The processor can be a general-purpose processor, a digital signal processor (DSP), a field programmable gate array (FPGA), or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. Among them, the general-purpose processor can be a central processing unit (CPU), a microprocessor (MPU) or any other conventional processor.

[0163] Embodiment 2

[0164] The embodiment of the application provides a respiratory control system during anesthesia, referring to Figure 7 , the airway control system during anesthesia includes:

[0165] Electrode equipment;

[0166] The airway control device during anesthesia described in the aforementioned embodiment; the airway control device during anesthesia is communicatively connected to the electrode device, and the electrode device is used to increase or decrease the intensity of electrical stimulation to the biological tissue associated with the airway.

[0167] In the respiratory control system during anesthesia provided in the embodiment of the present application, the electrode device may be, for example, an electrical stimulation electrode (more specifically, for example, a medium frequency electrode), which determines a comprehensive respiratory assessment value of the target organism through at least two respiratory parameters that characterize the patency of the respiratory tract, and increases or decreases the intensity of electrical stimulation of biological tissue associated with the respiratory tract through the electrode device based on the numerical value of the comprehensive respiratory assessment value, so as to improve the patency of the respiratory tract. This improves the level of control over the respiratory tract during anesthesia and can better ensure the safety and comfort of the target organism.

[0168] In some embodiments, please refer to Figure 7 , the airway control system during anesthesia may also include:

[0169] an electromyographic electrode, used for connecting to a target organism to measure diaphragm electromyographic parameters;

[0170] A sensor for connecting to a target organism to measure respiratory flow and / or SpO2;

[0171] Nasal oxygen cannula for connection to a target organism to measure ETCO2.

[0172] In the present application, please continue to refer to Figure 7 The electronic device corresponding to the respiratory control device during anesthesia may include a main control chip and a stimulation waveform control circuit, a diaphragm myoelectric acquisition circuit, a respiratory flow acquisition circuit, an ETCO2 module, and an SpO2 module connected to the main control chip. The stimulation waveform control circuit is connected to the electrical stimulation electrode, the diaphragm myoelectric acquisition circuit is connected to the myoelectric electrode, the respiratory flow acquisition circuit is connected to the respiratory flow sensor, the ETCO2 module is connected to the nasal oxygen tube, and the SpO2 module is connected to the SpO2 sensor.

[0173] In the stimulation waveform control circuit, the medium frequency stimulation uses a constant current source, and the medium frequency current intensity is 0 to 150mA. Considering that the human body impedance is generally 0.5KΩ to 5KΩ, a DC-DC boost voltage is also used to boost the stimulation waveform control circuit to meet the maximum stimulation current requirements. The current direction on the stimulation circuit is bidirectional, and a bridge is used to switch the current direction to control the stimulation; the constant current source uses op amp feedback, and the digital-to-analog converter DAC controls the current size. The analog-to-digital converter ADC samples the stimulation current for feedback adjustment.

[0174] The electromyography circuit uses an electrocardiogram or electroencephalogram chip front end, such as TI's ADS1299 series chips, to simplify the circuit design. Both the electromyography electrodes and the intermediate frequency electrodes can use hydrogel electrodes, which have low contact impedance, are easy to use, and are low in cost.

[0175] The respiration sensor uses a temperature sensor for respiration monitoring, and specifically, the temperature sensor is preferably a thermistor. The measurement of ETCO2 and SpO2 can both use measurement module technology well known to those skilled in the art.

[0176] In some specific embodiments, the respiratory control system during anesthesia can also be powered by a rechargeable lithium battery to ensure that the device terminal does not work when the power is suddenly cut off, and the battery can continue to work for a long time to avoid temporary power outages. In some other embodiments of the present application, an AC-DC power supply can also be used, such as a medical safety power supply, to ensure the safety and reliability of user use. The characteristics of the medical safety power supply are isolation of DC above 4kV and low leakage current.

[0177] In some specific embodiments, the respiratory control system during anesthesia can also be provided with buttons, display screens, clock chips, sound circuits and speakers. Operation configuration processing can be performed through buttons, and other smart terminals or PCs can be connected through WiFi / Bluetooth networks. At the same time, the system time can also automatically obtain standard time through the Internet to ensure the accuracy of alarm setting, and information can also be displayed on the display screen.

[0178] The description of the above system embodiment is similar to the description of the above device embodiment, and has similar beneficial effects as the device embodiment. For technical details not disclosed in the system of this embodiment, please refer to the description of the device embodiment in this application for understanding.

[0179] Embodiment 3

[0180] The present application embodiment provides a computing device 800, referring to Figure 8 , the computing device 800 includes a storage component 801, a communication bus 802 and a processing component 803, wherein:

[0181] Storage component 801, used for storing the operating program of the airway control device during anesthesia;

[0182] Communication bus 802, used to realize the connection and communication between the storage component and the processing component;

[0183] The processing component 803 is used to execute the operating program of the airway control device during anesthesia to achieve the following steps:

[0184] Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract;

[0185] determining a comprehensive respiratory tract assessment of the target organism based on at least two respiratory parameters;

[0186] According to the value of the comprehensive respiratory assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

[0187] The type or structure of the storage component 801 can be found in the storage medium below, and will not be described in detail here.

[0188] The processing component 803 may be a general-purpose processor, a digital signal processor (DSP), a field programmable gate array (FPGA), or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. The general-purpose processor may be a central processing unit (CPU), a microprocessor (MPU), or any other conventional processor.

[0189] The computing device provided in the embodiment of the present application determines a comprehensive respiratory assessment value of a target organism through at least two respiratory parameters that characterize the patency of the respiratory tract, and increases or decreases the intensity of electrical stimulation to biological tissue associated with the respiratory tract based on the numerical value of the comprehensive respiratory assessment value to improve the patency of the respiratory tract, thereby improving the level of control over the respiratory tract during anesthesia and better ensuring the safety and comfort of the target organism.

[0190] In some embodiments, the computing device 800 may further include: an input device 804, an output device 805, and an external communication interface 806, and these components are interconnected via a bus system and / or other forms of connection mechanisms (not shown in the figure). In this embodiment, the input device 804 may be a network connector, an analog-to-digital converter, etc., and the output device 805 may be a display, a speaker, etc.

[0191] In some embodiments, the input device 804 may also include, for example, a keyboard, a mouse, a microphone, etc. The output device 805 may output various information to the outside, for example, in addition to the above-mentioned display and speaker, it may also be a printer, a projector, and a communication network and its connected remote output device, etc. The external communication interface 806 may be wired, such as a standard serial port (RS232), a general-purpose interface bus (GPIB) interface, an Ethernet interface, a universal serial bus (USB) interface, or wireless, such as wireless network communication technology (WiFi), Bluetooth, etc.

[0192] The description of the above device embodiment is similar to the description of the above apparatus embodiment, and has similar beneficial effects as the apparatus embodiment. For technical details not disclosed in the device of this embodiment, please refer to the description of the apparatus embodiment in this application for understanding.

[0193] Embodiment 4

[0194] The present application provides a computer-readable storage medium, on which an executable program is stored.

[0195] When an executable program is executed by a processor, the following steps are implemented:

[0196] Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract;

[0197] determining a comprehensive respiratory tract assessment of the target organism based on at least two respiratory parameters;

[0198] According to the value of the comprehensive respiratory assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

[0199] The storage medium provided in the embodiment of the present application determines a comprehensive respiratory assessment value of a target organism through at least two respiratory parameters that characterize the patency of the respiratory tract, and increases or decreases the intensity of electrical stimulation to biological tissue associated with the respiratory tract based on the numerical value of the comprehensive respiratory assessment value to improve the patency of the respiratory tract, thereby improving the level of control over the respiratory tract during anesthesia and better ensuring the safety and comfort of the target organism.

[0200] Exemplarily, the computer-readable storage medium can adopt any combination of one or more readable media. The readable medium can be a readable signal medium or a readable storage medium. The computer-readable storage medium is a tangible device that can hold and store instructions used by the instruction execution device. The readable storage medium can include, for example, but is not limited to, electrical, magnetic, optical, electromagnetic, infrared, or semiconductor systems, devices or devices, or any combination of the above. More specific examples (non-exhaustive list) of readable storage media include: portable computer disks, hard disks, random access memory (RAM, Random Access Memory), read-only memory (ROM, Read Only Memory), flash memory (Flash Memory), portable compact disc read-only memory (CD-ROM, Compact Disc Read-Only Memory), digital versatile disk (DVD, Digital Versatile Disc), memory stick, floppy disk, mechanical encoding device, such as a punch card or a protruding structure in a groove on which instructions are stored, and any suitable combination of the above. Wherein:

[0201] The RAM includes: static random access memory (SRAM), synchronous static random access memory (SSRAM), dynamic random access memory (DRAM), synchronous dynamic random access memory (SDRAM), double data rate synchronous dynamic random access memory (DDRSDRAM), enhanced synchronous dynamic random access memory (ESDRAM), synchronous link dynamic random access memory (SLDRAM, SyncLink Dynamic Random Access Memory), and direct RAM bus random access memory (DRRAM, Direct Rambus Random Access Memory).

[0202] The ROM includes: a programmable read-only memory (PROM), an erasable programmable read-only memory (EPROM), and an electrically erasable programmable read-only memory (EEPROM).

[0203] The computer-readable storage medium used herein is not to be construed as a transient signal per se, such as a radio wave or other freely propagating electromagnetic wave, an electromagnetic wave propagating through a waveguide or other transmission medium (e.g., light pulses through a fiber optic cable), or an electrical signal transmitted through wires.

[0204] The description of the above computer-readable storage medium embodiment is similar to the description of the above device embodiment, and has similar beneficial effects as the device embodiment. For technical details not disclosed in the computer-readable storage medium of this embodiment, please refer to the description of the device embodiment in this application for understanding.

[0205] It should be noted that the device, system, equipment and storage medium embodiments provided in the embodiments of the present application belong to the same concept; the technical features in the technical solutions recorded in each embodiment can be combined arbitrarily without conflict.

[0206] The present application embodiment can be a system, method and / or computer program product. The computer program product can include a computer-readable storage medium, which is loaded with a computer-readable program instruction for making a processor realize various aspects of the present application. The computer program product can be written in any combination of one or more programming languages ​​to perform the program code for performing the operation of the present application embodiment, and the programming language includes an object-oriented programming language, such as Java, C++, etc., and also includes a conventional procedural programming language, such as "C" language or similar programming language. The program code can be executed completely on the user's computer, partially on the user's device, as an independent software package, partially on the user's computer, partially on the remote computer, or completely on the remote computer or server. In the case of a remote computer, the remote computer can be connected to the user's computer by any type of network-including a local area network (LAN) or a wide area network (WAN), or it can be connected to an external computer (for example, using an Internet service provider to connect to the Internet). In some embodiments, by utilizing the state information of computer-readable program instructions to personalize an electronic circuit, such as a programmable logic circuit, a field programmable gate array (FPGA), or a programmable logic array (PLA), the electronic circuit can execute the computer-readable program instructions to implement various aspects of the present application.

[0207] The computer-readable program instructions described herein can be downloaded from a computer-readable storage medium to each computing / processing device, or downloaded to an external computer or external storage device via a network, such as the Internet, a local area network, a wide area network, and / or a wireless network. The network can include copper transmission cables, optical fiber transmissions, wireless transmissions, routers, firewalls, switches, gateway computers, and / or edge servers. The network adapter card or network interface in each computing / processing device receives the computer-readable program instructions from the network and forwards the computer-readable program instructions for storage in the computer-readable storage medium in each computing / processing device.

[0208] Various aspects of the present application are described herein with reference to the flowcharts and / or block diagrams of the methods, devices (systems) and computer program products according to the embodiments of the present application. It should be understood that each box in the flowchart and / or block diagram and the combination of each box in the flowchart and / or block diagram can be implemented by computer-readable program instructions.

[0209] These computer-readable program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, or other programmable data processing device, thereby producing a machine, so that when these instructions are executed by the processor of the computer or other programmable data processing device, a device that implements the functions / actions specified in one or more boxes in the flowchart and / or block diagram is generated. These computer-readable program instructions can also be stored in a computer-readable storage medium, and these instructions cause the computer, programmable data processing device, and / or other equipment to work in a specific manner, so that the computer-readable medium storing the instructions includes a manufactured product, which includes instructions for implementing various aspects of the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0210] Computer-readable program instructions may also be loaded onto a computer, other programmable data processing apparatus, or other device so that a series of operating steps are performed on the computer, other programmable data processing apparatus, or other device to produce a computer-implemented process, thereby causing the instructions executed on the computer, other programmable data processing apparatus, or other device to implement the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0211] In the following description, the terms "first\second\..." are only used to distinguish similar objects and do not represent a specific order of the objects. It can be understood that "first\second\third" can be interchanged in a specific order or sequence where permitted.

[0212] The purpose of the terms used herein is only to describe specific embodiments and is not intended to be limiting of the present application. When used herein, the singular forms "one", "an" and "said / the" are also intended to include plural forms, unless the context clearly indicates otherwise. It should also be understood that the terms "consisting of" and / or "comprising", when used in this specification, determine the presence of the features, integers, steps, operations, elements and / or parts, but do not exclude the presence or addition of one or more other features, integers, steps, operations, elements, parts and / or groups. When used herein, the term "and / or" includes any and all combinations of the relevant listed items.

[0213] It should be understood that "one embodiment" or "some embodiments" mentioned throughout the specification means that specific features, structures or characteristics related to the embodiment are included in at least one embodiment of the present application. Therefore, "in one embodiment" or "in some embodiments" appearing throughout the specification may not necessarily refer to the same embodiment. In addition, these specific features, structures or characteristics can be combined in one or more embodiments in any suitable manner. It should be understood that in various embodiments of the present application, the size of the sequence number of the above-mentioned processes does not mean the order of execution, and the execution order of each process should be determined by its function and internal logic, and should not constitute any limitation on the implementation process of the embodiments of the present application. The above-mentioned sequence numbers of the embodiments of the present application are for description only and do not represent the advantages and disadvantages of the embodiments.

[0214] In the several embodiments provided in the present application, it should be understood that the disclosed devices and methods can be implemented in other ways. The device embodiments described above are only schematic. For example, the division of the modules is only a logical function division. There may be other division methods in actual implementation, such as: multiple modules or components can be combined, or can be integrated into another system, or some features can be ignored, or not executed. In addition, the coupling, direct coupling, or communication connection between the components shown or discussed can be through some interfaces, and the indirect coupling or communication connection of the devices or modules can be electrical, mechanical or other forms.

[0215] The modules described above as separate components may or may not be physically separated, and the components displayed as modules may or may not be physical modules; they may be located in one place or distributed on multiple network modules; some or all of the modules may be selected according to actual needs to achieve the purpose of the present embodiment.

[0216] In addition, all functional modules in the embodiments of the present application may be integrated into one processing module, or each functional module may be a separate module, or two or more functional modules may be integrated into one module; the above-mentioned integrated modules may be implemented in the form of hardware or in the form of hardware plus software functional modules.

[0217] A person skilled in the art can understand that all or part of the steps of implementing the above method embodiment can be completed by hardware related to program instructions, and the aforementioned program can be stored in a computer-readable storage medium. When the program is executed, it executes the steps including the above method embodiment.

[0218] Alternatively, if the above-mentioned integrated module of the present application is implemented in the form of a software function module and sold or used as an independent product, it can also be stored in a computer-readable storage medium. Based on such an understanding, the technical solution of the embodiment of the present application can be essentially or the part that contributes to the prior art can be embodied in the form of a software product, and the computer software product is stored in a storage medium, including several instructions to enable an electronic device (which can be a personal computer, a server, or a network device, etc.) to execute all or part of the methods described in each embodiment of the present application. In this way, the embodiment of the present application is not limited to any specific combination of hardware and software.

[0219] The methods disclosed in several method embodiments provided in this application can be combined arbitrarily without conflict to obtain new method embodiments. The features disclosed in several product embodiments provided in this application can be combined arbitrarily without conflict to obtain new product embodiments.

[0220] It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also includes other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the presence of other identical elements in the process, method, article or device including the element.

[0221] It should be understood that the above embodiments are exemplary and are not intended to include all possible implementations included in the claims. Various modifications and changes may be made on the basis of the above embodiments without departing from the scope of the present disclosure. Similarly, the various technical features of the above embodiments may be arbitrarily combined to form other embodiments of the present application that may not be explicitly described. Therefore, the above embodiments only express several implementations of the present application and do not limit the scope of protection of the patent of this application.

Claims

1. A respiratory control device during anesthesia, characterized in that: include: A first acquisition module is used to acquire at least two respiratory parameters representing the patency of the respiratory tract of the target organism; a determination module, configured to determine a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters; The control module is used to increase or decrease the intensity of electrical stimulation to the biological tissue associated with the respiratory tract according to the numerical value of the comprehensive respiratory tract evaluation value, so as to improve the patency of the respiratory tract.

2. The airway control device during anesthesia according to claim 1, characterized in that: The first acquisition module is specifically used for: The values ​​of the at least two respiratory parameters of the target organism before and after anesthesia are obtained.

3. The airway control device during anesthesia according to claim 2, characterized in that: The at least two respiratory parameters include: diaphragm electromyographic parameters and respiratory flow parameters; The first acquisition module is also used for: obtaining a first diaphragm electromyographic value and a first respiratory flow rate of the target organism before anesthesia; obtaining a second diaphragm myoelectric value and a second respiratory flow rate of the target organism after anesthesia; The first diaphragm EMG value and the second diaphragm EMG value are respectively measured values ​​of the diaphragm EMG parameter, and the first respiratory flow and the second respiratory flow are respectively measured values ​​of the respiratory flow parameter.

4. The airway control device during anesthesia according to claim 3, characterized in that: The first acquisition module is also used for: Acquire a first respiratory resistance value and a second respiratory resistance value; The first respiratory resistance value is a ratio of the first respiratory flow rate to the first diaphragm myoelectric value; the second respiratory resistance value is a ratio of the second respiratory flow rate to the second diaphragm myoelectric value.

5. The airway control device during anesthesia according to claim 4, characterized in that: The determination module is specifically used for: normalizing the second respiratory flow to obtain a first intermediate parameter; Normalizing the second respiratory resistance value to obtain a second intermediate parameter; The first intermediate parameter and the second intermediate parameter are assigned different weights and then added to determine the comprehensive respiratory tract assessment value.

6. The airway control device during anesthesia according to claim 5, characterized in that: The determining module is also used for: Determine a minimum respiratory flow rate and a maximum respiratory flow rate according to the first respiratory flow rate; determining a first difference between the second respiratory flow and the minimum respiratory flow; determining a second difference between the maximum respiratory flow and the minimum respiratory flow; The first difference is divided by the second difference to perform normalization processing to obtain the first intermediate parameter.

7. The airway control device during anesthesia according to claim 6, characterized in that: The determining module is also used for: The first respiratory flow is multiplied by a first coefficient to obtain the maximum respiratory flow, and the first respiratory flow is multiplied by a second coefficient to obtain the minimum respiratory flow; the first coefficient is 0.5-1.2, and the second coefficient is 0.3-0.8; the maximum respiratory flow is greater than the minimum respiratory flow.

8. The airway control device during anesthesia according to claim 5, characterized in that: The determining module is also used for: Determine a minimum respiratory resistance value and a maximum respiratory resistance value according to the first respiratory resistance value; determining a third difference between the second breathing resistance value and the minimum breathing resistance value; determining a fourth difference between the maximum breathing resistance value and the minimum breathing resistance value; The third difference is divided by the fourth difference to perform normalization processing to obtain the second intermediate parameter.

9. The airway control device during anesthesia according to claim 8, characterized in that: The determining module is also used for: The first respiratory resistance value is multiplied by a third coefficient to obtain the maximum respiratory resistance value, and the first respiratory resistance value is multiplied by a fourth coefficient to obtain the minimum respiratory resistance value; the third coefficient is 0.5-1.2, and the fourth coefficient is 0.3-0.8; the maximum respiratory resistance value is greater than the minimum respiratory resistance value.

10. The airway control device during anesthesia according to any one of claims 1 to 9, characterized in that: The control module is specifically used for: When the comprehensive respiratory tract assessment value is less than or equal to a first preset value, the intensity of the electrical stimulation is controlled to increase; when the comprehensive respiratory tract assessment value is greater than or equal to a second preset value, the intensity of the electrical stimulation is controlled to decrease; otherwise, the intensity of the electrical stimulation is kept unchanged.

11. The airway control device during anesthesia according to any one of claims 1 to 9, characterized in that: The device also includes: The second acquisition module is used to acquire at least one monitoring parameter of the target organism; the at least one monitoring parameter includes end-tidal carbon dioxide and / or blood oxygen saturation.

12. The airway control device during anesthesia according to claim 11, characterized in that: The device also includes: The monitoring module is used to issue an alarm message when it is detected that at least one monitoring parameter exceeds a preset range.

13. A respiratory control system during anesthesia, characterized in that: include: Electrode equipment; The airway control device during anesthesia according to any one of claims 1 to 12; The airway control device during anesthesia is communicatively connected to the electrode device, and the electrode device is used to increase or decrease the intensity of electrical stimulation to biological tissue associated with the airway.

14. A computing device, characterized in that It includes a storage component, a communication bus and a processing component, wherein: The storage component is used to store the operating program of the airway control device during anesthesia; The communication bus is used to realize the connection and communication between the storage component and the processing component; The processing component is used to execute the operating program of the airway control device during anesthesia to achieve the following steps: Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract; determining a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters; According to the numerical value of the comprehensive respiratory tract assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.

15. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores an executable program. When the executable program is executed by the processor, the following steps are implemented: Acquiring at least two respiratory parameters of the target organism that characterize the patency of the respiratory tract; determining a comprehensive respiratory assessment value of the target organism based on the at least two respiratory parameters; According to the numerical value of the comprehensive respiratory tract assessment value, the intensity of electrical stimulation to the biological tissue associated with the respiratory tract is increased or decreased to improve the patency of the respiratory tract.